Table 1.
Phenotypic drug susceptibility testing profile | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | Total |
---|---|---|---|---|---|---|---|---|---|---|
Total number of isolates tested | 18 | 53 | 33 | 15 | 10 | 29 | 53 | 87 | 39 | 337 |
Pan susceptible | 18 | 37 | 22 | 2 | 1 | 16 | 34 | 63 | 17 | 210 |
S | 0 | 1 | 3 | 0 | 0 | 0 | 2 | 8 | 2 | 16 |
I | 0 | 0 | 1 | 1 | 0 | 2 | 4 | 2 | 2 | 12 |
R | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 |
E | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 |
S, I | 0 | 1 | 2 | 2 | 0 | 0 | 1 | 5 | 5 | 16 |
S, I, E | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 3 |
S, R | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
S, R, E | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
S, I, R | 0 | 2 | 0 | 0 | 2 | 0 | 0 | 0 | 1 | 5 |
I, R, E | 0 | 2 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 5 |
I, R | 0 | 1 | 1 | 0 | 0 | 3 | 1 | 0 | 4 | 10 |
S, I, R, E | 0 | 7 | 3 | 9 | 7 | 7 | 9 | 8 | 5 | 55 |
Total # of MDR-TB per Year | 0 | 12 | 5 | 10 | 9 | 11 | 10 | 8 | 10 | 75 |
% of MDR-TB per Year | 0.00 | 22.6 | 15.2 | 66.7 | 90.0 | 37.9 | 18.9 | 9.2 | 25.6 | 22.3 |
S streptomycin, I isoniazid, R rifampicin, E ethambutol, MDR-TB multidrug resistance (resistance to at least isoniazid and rifampicin)